This report presents an exhaustive fundamental, technical, and macroeconomic analysis of Intuitive Surgical, Inc. (NASDAQ: ISRG), the pioneering developer of robotic-assisted surgical systems. As of July 22, 2026, the company operates in a highly complex macroeconomic environment characterized by slowing U.S. surgical procedures, shifting regulatory frameworks under the current U.S. administration, and evolving competitive dynamics in the medical technology sector.

Despite these headwinds, Intuitive Surgical reported robust second-quarter 2026 results, generating $2.89 billion in revenue and placing 468 da Vinci systems1. The analysis evaluates the company's 5-year financial trajectory, proprietary technological moat, capital allocation efficiency, and equity dilution mechanisms to determine its intrinsic and relative valuation across mult ...